Repligen Corp (RGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RGEN | ROIV | ASND | ||
| Company | Repligen Corp | Roivant Sciences Ltd | Ascendis Pharma ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 145.26 | 11.68 | 129.28 | ||
| High | 146.35 | 11.86 | 129.28 | ||
| Low | 142.95 | 11.68 | 126.26 | ||
| Last | 143.88 | 11.76 | 126.55 | ||
| Change | -2.05 | +0.01 | -2.81 | ||
| % Change | -1.40% | +0.09% | -2.17% | ||
| Volume | 357,105 | 2,584,826 | 266,594 | ||
| 20-Day Average Volume | 534,895 | 3,429,041 | 349,755 | ||
| Previous Close | 145.93 | 11.75 | 129.36 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 140.61 | 11.76 | 127.70 | ||
| 20-Day Raw Stochastic | 50.65% | 52.94% | 43.79% | ||
| 20-Day Relative Strength | 52.24% | 51.45% | 44.90% | ||
| Weighted Alpha | -7.72 | +27.94 | +12.73 | ||
| Today's Opinion | 32% Sell | 56% Buy | 100% Sell | ||
| Previous Opinion | 32% Sell | 48% Buy | 88% Sell | ||
| Last Month's Opinion | 88% Sell | 56% Buy | 32% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.16% since 10/31/24 | +1.82% since 10/31/24 | +3.04% since 10/31/24 | ||
| Low | 134.27 on 11/01/24 | 11.40 on 11/05/24 | 121.51 on 11/01/24 | ||
| High | 150.78 on 11/06/24 | 11.99 on 11/06/24 | 132.46 on 11/06/24 | ||
| 1-Month | |||||
| %Chg | +5.34% since 10/07/24 | +4.91% since 10/07/24 | -9.05% since 10/07/24 | ||
| Low | 133.34 on 10/10/24 | 11.16 on 10/09/24 | 120.77 on 10/31/24 | ||
| High | 154.11 on 10/17/24 | 12.08 on 10/28/24 | 143.53 on 10/08/24 | ||
| 3-Month | |||||
| %Chg | -11.45% since 08/07/24 | +15.63% since 08/07/24 | +2.37% since 08/07/24 | ||
| Low | 133.34 on 10/10/24 | 10.05 on 08/08/24 | 111.09 on 09/12/24 | ||
| High | 166.97 on 08/08/24 | 13.06 on 09/09/24 | 155.53 on 09/20/24 | ||
| 6-Month | |||||
| %Chg | -14.21% since 05/07/24 | +3.34% since 05/07/24 | -6.93% since 05/07/24 | ||
| Low | 113.50 on 06/20/24 | 10.00 on 08/05/24 | 111.09 on 09/12/24 | ||
| High | 176.94 on 05/15/24 | 13.06 on 09/09/24 | 155.53 on 09/20/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,173,100 | 8,689,383 | 7,844,648 | ||
| Shares Outstanding, K | 56,007 | 739,522 | 60,642 | ||
| Annual Sales | 638,760,000 | 124,800,000 | 288,670,000 | ||
| Annual Net Income | 41,580,000 | 4,348,930,000 | -521,070,000 | ||
| Last Quarter Sales | 154,070,000 | 55,130,000 | 38,770,000 | ||
| Last Quarter Net Income | 3,320,000 | 95,300,000 | -117,790,000 | ||
| 60-Month Beta | 0.96 | 1.24 | 0.66 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.33 on 07/30/24 | -0.18 on 08/08/24 | -2.05 on 09/03/24 | ||
| Latest Earnings Date | 11/12/24 | 11/12/24 | 11/05/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 124.74 | 0.00 | 0.00 | ||